# RxSight, Inc. to Present at the Bank of America Healthcare Conference
Canonical URL: https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-bank-of-america-healthcare-conference
Ticker: RXST
Company: RxSight
Source: RxSight
Published: 2026-04-29 20:10 EST
Original Source URL: https://investors.rxsight.com
## Summary

ALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participate in a fireside chat on Wednesday, May 13, 2026, at 3:00 p.m. Pacific Time.

## Article Body
ALISO VIEJO, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- RxSight, Inc., today announced plans to participate in the upcoming Bank of America Healthcare Conference. Management is scheduled to participate in a fireside chat on Wednesday, May 13, 2026, at 3:00 p.m. Pacific Time.
## Recent Company News
- 2026-05-19 20:10 EST — [RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum](https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-stifel-2026-virtual-ophthalmology-forum) — Source: RxSight
- 2026-05-06 20:05 EST — [RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook](https://biopharmsignal.com/news/RXST/rxsight-inc-reports-first-quarter-2026-results-and-reiterates-full-year-sales-outlook) — Source: RxSight
- 2026-04-29 20:10 EST — [RxSight, Inc. to Present at the Bank of America Healthcare Conference](https://biopharmsignal.com/news/RXST/rxsight-inc-to-present-at-the-bank-of-america-healthcare-conference) — Source: RxSight
- 2026-04-22 20:10 EST — [RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6](https://biopharmsignal.com/news/RXST/rxsight-inc-to-report-first-quarter-2026-financial-results-on-may-6) — Source: RxSight
- 2026-04-08 20:05 EST — [RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026](https://biopharmsignal.com/news/RXST/rxsight-highlights-300-000-light-adjustable-lens-implant-milestone-and-strong-scientific-presence-at-ascrs-2026) — Source: RxSight
## Related News
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)
- 2026-07-21 11:30 EST — ABEO — [Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®](https://biopharmsignal.com/news/ABEO/cincinnati-children-s-activated-as-the-seventh-qualified-treatment-center-for-ze-8382d043)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)